192 filings
Page 3 of 10
8-K
vq426 jecny2zv
20 Nov 23
Departure of Directors or Certain Officers
5:08pm
8-K
t1tm5v 5pzzst
9 Nov 23
Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
7:03am
8-K
3im94x6l190efky3 ogs
30 Oct 23
Results of Operations and Financial Condition
4:14pm
EFFECT
t395vexkkp974o
17 Oct 23
Notice of effectiveness
12:15am
CORRESP
6rn76imwa0
12 Oct 23
Correspondence with SEC
12:00am
PRE 14A
wv68m
6 Oct 23
Preliminary proxy
4:15pm
UPLOAD
2ll8teiv5t 856
22 Aug 23
Letter from SEC
12:00am
D
8wavxfv2tdpr9mku
11 Aug 23
$2.11 mm in equity, sold $2.11 mm, 10 investors
4:01pm
424B5
iltbw
9 Aug 23
Prospectus supplement for primary offering
4:37pm
8-K
ja870h3qglw019po7r
9 Aug 23
Better Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:07pm
8-K
un6o q4oo
26 Jul 23
Better Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Share
5:11pm
424B5
hwl68k4fpyvw5d tlq8
26 Jul 23
Prospectus supplement for primary offering
5:04pm
8-K
0wzl2wvj sdtnsv3ixkn
12 Jul 23
Better Therapeutics Receives FDA Authorization for AspyreRxTM to Treat Adults with Type 2 Diabetes
12:00am